Drug Type Gene therapy |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscular Dystrophies, Limb-Girdle | Preclinical | FR | 26 Aug 2024 | |
Muscular Dystrophies, Limb-Girdle | Preclinical | FR | Atamyo Therapeutics SASStartup | 26 Aug 2024 |